Document is current

Any future updates will be listed below

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

Crossref DOI link: https://doi.org/10.1186/S12885-015-2046-7

Published Online: 2016-01-11

Published Print: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark